IL99224A - Pharmaceutical preparations containing antipsychotic and radical scavenger - Google Patents

Pharmaceutical preparations containing antipsychotic and radical scavenger

Info

Publication number
IL99224A
IL99224A IL9922491A IL9922491A IL99224A IL 99224 A IL99224 A IL 99224A IL 9922491 A IL9922491 A IL 9922491A IL 9922491 A IL9922491 A IL 9922491A IL 99224 A IL99224 A IL 99224A
Authority
IL
Israel
Prior art keywords
clozapine
ascorbic acid
radical scavenger
radical
pharmaceutical composition
Prior art date
Application number
IL9922491A
Other languages
English (en)
Hebrew (he)
Other versions
IL99224A0 (en
Inventor
Volker Fischer
Ronald Paul Mason
Original Assignee
Sandoz Sa
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa, Us Commerce filed Critical Sandoz Sa
Publication of IL99224A0 publication Critical patent/IL99224A0/xx
Publication of IL99224A publication Critical patent/IL99224A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9922491A 1990-08-20 1991-08-19 Pharmaceutical preparations containing antipsychotic and radical scavenger IL99224A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56968990A 1990-08-20 1990-08-20
US71713691A 1991-06-18 1991-06-18

Publications (2)

Publication Number Publication Date
IL99224A0 IL99224A0 (en) 1992-07-15
IL99224A true IL99224A (en) 1996-01-31

Family

ID=27075116

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9922491A IL99224A (en) 1990-08-20 1991-08-19 Pharmaceutical preparations containing antipsychotic and radical scavenger

Country Status (30)

Country Link
US (2) US5312819A (it)
JP (1) JPH0813745B2 (it)
KR (1) KR100189349B1 (it)
AT (1) AT400522B (it)
AU (1) AU649269B2 (it)
BE (1) BE1006878A5 (it)
CA (1) CA2065421A1 (it)
CH (1) CH684162A5 (it)
CZ (1) CZ281843B6 (it)
DE (1) DE4191979T (it)
DK (1) DK51292A (it)
ES (1) ES2078838B1 (it)
FI (1) FI913888A (it)
FR (1) FR2665835B1 (it)
GB (1) GB2254252B (it)
GR (1) GR1002188B (it)
HU (1) HUT60137A (it)
IE (1) IE66121B1 (it)
IL (1) IL99224A (it)
IT (1) IT1251226B (it)
LU (1) LU88099A1 (it)
MX (1) MX9100742A (it)
MY (1) MY107976A (it)
NL (1) NL9120006A (it)
NZ (1) NZ239464A (it)
PT (1) PT98707B (it)
RU (1) RU2080860C1 (it)
SE (1) SE9201189D0 (it)
SK (1) SK279225B6 (it)
WO (1) WO1992003138A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008801A1 (en) * 1991-10-31 1993-05-13 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Prevention of drug-induced agranulocytosis with free radical scavengers
US5538965A (en) * 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
JP3889481B2 (ja) * 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
DK1026950T3 (da) * 1997-10-27 2006-06-26 Univ California Behandling af skizofreni med ampakiner og neuroleptika
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
JP2003026567A (ja) * 2001-05-10 2003-01-29 Kanegafuchi Chem Ind Co Ltd 補酵素ｑを有効成分とする粘膜投与用組成物
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
EP2299983A4 (en) * 2008-07-24 2012-10-10 Handa Pharmaceuticals Llc ATYPICAL ANTIPSYCHOTIC FORMULATION STABILIZED
RU2610169C2 (ru) * 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" ПРОИЗВОДНЫЕ 7-ФТОРО-8-ХЛОРО-5Н-ДИБЕНЗО[b, е][1, 4]ДИАЗЕПИНА И ИХ ПРИМЕНЕНИЕ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI50242C (fi) * 1969-07-18 1976-01-12 Thomae Gmbh Dr K Menetelmä valmistaa farmakologisesti aktiivisia uusia diallyyliaminoal kanoyylidibenso- tai pyridobenso-diatsepiineja ja niiden happoadditios uoloja.
US3983234A (en) * 1974-07-04 1976-09-28 Sandoz Ltd. Treatment of dyskinesias
US4028467A (en) * 1975-01-07 1977-06-07 Berger Frank M Analgesic compositions comprising levo-propoxyphene and benzo diazepine and process
GB1498857A (en) * 1975-07-03 1978-01-25 Leo Ab Antidepressant composition
EP0026469B1 (en) * 1979-10-01 1984-11-28 Sandoz Ag Dibenzazepine derivatives, their production and pharmaceutical compositions containing them
US4761411A (en) * 1983-05-18 1988-08-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses
DE3542309A1 (de) * 1985-11-29 1987-06-04 Cardona Federico Dr Medizinisches antioxidativum
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
US4996199A (en) * 1988-04-08 1991-02-26 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物

Also Published As

Publication number Publication date
CS55092A3 (en) 1992-08-12
GR1002188B (en) 1996-03-13
FR2665835B1 (fr) 1995-06-23
NZ239464A (en) 1993-10-26
CH684162A5 (de) 1994-07-29
JPH05503296A (ja) 1993-06-03
NL9120006A (nl) 1992-08-03
GB2254252B (en) 1994-06-01
KR100189349B1 (en) 1999-06-01
FR2665835A1 (fr) 1992-02-21
MY107976A (en) 1996-07-15
ITMI912261A0 (it) 1991-08-20
GB9206101D0 (en) 1992-06-24
GB2254252A (en) 1992-10-07
SE9201189L (sv) 1992-04-14
DK51292D0 (da) 1992-04-15
AU649269B2 (en) 1994-05-19
SK279225B6 (sk) 1998-08-05
DE4191979T (it) 1992-10-08
ES2078838A1 (es) 1995-12-16
PT98707B (pt) 1999-01-29
ITMI912261A1 (it) 1993-02-20
AU8396391A (en) 1992-03-17
FI913888A0 (fi) 1991-08-16
RU2080860C1 (ru) 1997-06-10
IT1251226B (it) 1995-05-05
GR910100361A (el) 1992-08-31
ES2078838B1 (es) 1997-02-01
US5312819A (en) 1994-05-17
LU88099A1 (de) 1992-11-16
MX9100742A (es) 1992-04-01
BE1006878A5 (fr) 1995-01-17
HUT60137A (en) 1992-08-28
ATA900491A (de) 1995-06-15
HU9201090D0 (en) 1992-06-29
KR920702225A (ko) 1992-09-03
FI913888A (fi) 1992-02-21
IE66121B1 (en) 1995-12-13
CA2065421A1 (en) 1992-02-21
US5563134A (en) 1996-10-08
CZ281843B6 (cs) 1997-02-12
PT98707A (pt) 1992-07-31
IL99224A0 (en) 1992-07-15
JPH0813745B2 (ja) 1996-02-14
WO1992003138A1 (en) 1992-03-05
DK51292A (da) 1992-04-15
IE912934A1 (en) 1992-02-26
SE9201189D0 (sv) 1992-04-14
AT400522B (de) 1996-01-25

Similar Documents

Publication Publication Date Title
EP0882450B1 (en) Cholesterol-lowering composition comprising coenzyme Q
Dahl‐Puustinen et al. Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in luman beings
RU2289406C2 (ru) СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ПОНИЖЕНИЯ СОДЕРЖАНИЯ ЛИПОПРОТЕИНА (a) В ПЛАЗМЕ КРОВИ И УМЕНЬШЕНИЯ ФАКТОРОВ РИСКА СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ
US5880148A (en) Combination of fenofibrate and vitamin E, and method of use of same in therapeutic treatments
AU649269B2 (en) Improvements in or relating to organic compounds
Dahl et al. Disposition of the neuroleptic zuclopenthixol cosegregates with the polymorphic hydroxylation of debrisoquine in humans
Férnandez-Calle et al. Serum levels of ascorbic acid (vitamin C) in patients with Parkinson's disease
WO1998032434A1 (en) New analgesic composition
KR0131452B1 (ko) 양성 전립선 비대증 경우의 배뇨장애 치료용 나프토피딜
DK1285650T3 (en) METHOD AND COMPOSITION FOR INHIBITION OF atherosclerosis
Swick et al. Peritoneal dialysis in colistin intoxication: Report of a case
JP4693140B2 (ja) トコトリエノール含有医薬用剤
US5686494A (en) Pharmaceutical preparations for ameliorating epigastric functional disorders
Stahl et al. Serotonin accumulation by skeletal muscle
Tariq et al. Effect of selenium and vitamin E on iminodipropionitrile induced dyskinesia in rats
AU694112B2 (en) Method and composition for treatment of osteoporosis
WO1993008801A1 (en) Prevention of drug-induced agranulocytosis with free radical scavengers
Cerrato Cyclosporine and red wine don't mix very well
Herzele The individual and combined effects of ethanol and lovastatin on rat heart antioxidant status with emphasis on CoQ
AU2004280108A1 (en) Methods and means for modulating lipid metabolism
GB2177920A (en) Gastric compositions

Legal Events

Date Code Title Description
FF Patent granted
HC Change of name of proprietor(s)
KB Patent renewed